The aversive effect of a glutamate metabotropic receptor agonist injected into the dorsal periaqueductal grey may partially depend on glutamate release

被引：0
|
作者：
Guimaraes, F [1 ]
Molchanov, ML [1 ]
机构：
[1] Univ Sao Paulo, Sch Med, BR-14049 Ribeirao Preto, Brazil
来源：
EUROPEAN NEUROPSYCHOPHARMACOLOGY | 2003年 / 13卷
关键词：
D O I：
暂无
中图分类号：
R74 [神经病学与精神病学];
学科分类号：
摘要：
引用
收藏
页码：S355 / S355
页数：1
相关论文
共 50 条
  • [31] Ameliorative Effect of a Hippocampal Metabotropic Glutamate-Receptor Agonist on Histamine H1 Receptor Antagonist-Induced Memory Deficit in Rats
    Masuoka, Takayoshi
    Mikami, Azusa
    Kamei, Chiaki
    JOURNAL OF PHARMACOLOGICAL SCIENCES, 2010, 113 (01) : 41 - 47
  • [32] Metabotropic glutamate receptor agonist (1S,3R-ACPD) increased frontal cortex dopamine release in aged but not in young rats
    Pintor, A
    Tiburzi, F
    Pezzola, A
    Volpe, MT
    EUROPEAN JOURNAL OF PHARMACOLOGY, 1998, 359 (2-3) : 139 - 142
  • [33] ANTINOCICEPTIVE EFFECT OF BOTULINUM TOXIN A INVOLVES ALTERATIONS IN AMPA RECEPTOR EXPRESSION AND GLUTAMATE RELEASE IN SPINAL DORSAL HORN NEURONS
    Hong, Bin
    Yao, Lingling
    Ni, Linhui
    Wang, Li
    Hu, Xingyue
    NEUROSCIENCE, 2017, 357 : 197 - 207
  • [34] The group II metabotropic glutamate receptor agonist, LY354740, blocks immobilization-induced increases in catecholamine release in the rat medial prefrontal cortex
    Swanson, C
    Schoepp, DD
    Perry, K
    FASEB JOURNAL, 2003, 17 (04): : A628 - A628
  • [35] Novel mGluR- and CB1R-Independent Suppression of GABA Release Caused by a Contaminant of the Group I Metabotropic Glutamate Receptor Agonist, DHPG
    Lafourcade, Carlos A.
    Zhang, Longhua
    Alger, Bradley E.
    PLOS ONE, 2009, 4 (07):
  • [36] In vivo inhibition of veratridine-evoked release of striatal excitatory amino acids by the group II metabotropic glutamate receptor agonist LY354740 in rats
    Battaglia, G
    Monn, JA
    Schoepp, DD
    NEUROSCIENCE LETTERS, 1997, 229 (03) : 161 - 164
  • [37] Anticonvulsant and glutamate release-inhibiting properties of the highly potent metabotropic glutamate receptor agonist (2S,2′R,3′R)-2-(2′,3′-dicarboxycyclopropyl) glycine (DCG-IV)
    Attwell, PJE
    Kent, NS
    Jane, DE
    Croucher, MJ
    Bradford, HF
    BRAIN RESEARCH, 1998, 805 (1-2) : 138 - 143
  • [38] Effect of Chronic Gestational Treatment With the Adenosine A, Receptor Agonist R-Phenylisopropyladenosine on Metabotropic Glutamate Receptors/Phospholipase C Pathway in Maternal and Fetal Brain
    Leon, David A.
    Albasanz, Jose L.
    Castillo, Carlos A.
    Iglesias, Inmaculada
    Martin, Mairena
    JOURNAL OF NEUROSCIENCE RESEARCH, 2008, 86 (15) : 3295 - 3305
  • [39] Protective effect of LY379268, a selective group II metabotropic glutamate receptor agonist, on dizocilpine-induced neuropathological changes in rat retrosplenial cortex
    Okamura, N
    Hashimoto, K
    Shimizu, E
    Koike, K
    Ohgake, S
    Koizumi, H
    Kumakiri, C
    Komatsu, N
    Iyo, M
    BRAIN RESEARCH, 2003, 992 (01) : 114 - 119
  • [40] Neuroprotective effect of LY379268, a Group II metabotropic glutamate receptor agonist, on hypoxic-ischemic brain injury in a neonatal rat model.
    Rhodes, PG
    Xiao, F
    Cai, Z
    JOURNAL OF NEUROCHEMISTRY, 2000, 74 : S71 - S71
12345